Clinical Drug Experience Knowledgebase

acetylsalicylic acid (aspirin) (1 trial)

bevacizumab (avastin) (1 trial)

capecitabine (xeloda) (3 trials)

cetuximab (erbitux) (2 trials)

cisplatin (platinol) (3 trials)

docetaxel (taxotere) (2 trials)

epirubicin (ellence) (1 trial)

fluorouracil (efudex) (6 trials)

gemcitabine (gemzar) (4 trials)

imatinib (gleevec) (2 trials)

irinotecan (Camptosar) (3 trials)

leucovorin (4 trials)

mitomycin (mutamycin) (1 trial)

nedaplatin (1 trial)

nivolumab (opdivo) (2 trials)

oxaliplatin (eloxatin) (3 trials)

paclitaxel (taxol) (5 trials)

regorafenib (stivarga) (3 trials)

tipiracil (lonsurf) (1 trial)

trifluridine (viroptic) (1 trial)

aprepitant (Emend) (1 trial)

bnc 105p (1 trial)

carboplatin (paraplatin) (2 trials)

cend-1 (1 trial)

dexamethasone (1 trial)

durvalumab (imfinzi) (1 trial)

Filgrastim (neupogen) (2 trials)

napabucasin (1 trial)

octreotate (1 trial)

ondansetron (zofran) (1 trial)

panitumumab (vectibix) (1 trial)

temozolomide (temodar) (1 trial)

valproic acid (depakene) (1 trial)